Fast Five Quiz: Management of Inherited Retinal Diseases

Donny W. Suh, MD, MBA


April 27, 2022

The treatment options available to patients with IRD are limited. However, numerous clinical trials are currenting investigating possible agents that target specific genes. Genetic testing plays an important role in accurately identifying specific mutations, enabling patients with an IRD to participate in clinical trials. In addition, with genetic counseling, patients and families can discuss the impact of the diagnosis and provide a clear understanding of how the results will affect their immediate and future care.

Most IRDs are characterized by progressive vision loss, which can have a substantial effect on quality of life. A multidisciplinary approach can educate patients and provide a clear understanding of what to expect after the diagnosis of IRD. In addition, encouraging low-vision rehabilitation and support groups may be beneficial to patients. Studies have shown that positive coping improves quality of life.

Dietary restrictions are not known to influence IRD.

Learn more about inherited retinal diseases.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.